Can you provide an overview of cephalosporin antibiotics, including their generations, typical clinical uses, dosing regimens, and contraindications?

Cephalosporin Antibiotics: Clinical Overview

Generational Classification and Spectrum

Cephalosporins are beta-lactam antibiotics divided into five generations, each with distinct antimicrobial coverage and clinical applications 1, 2.

First-Generation Cephalosporins

First-generation agents (cephalexin oral, cefazolin IV) are the preferred choice for uncomplicated skin and soft tissue infections and surgical prophylaxis for most clean procedures 1.

• Spectrum: Excellent gram-positive coverage (streptococci, methicillin-sensitive staphylococci), limited gram-negative activity 3
• Key agents: Cephalexin (oral), cefazolin (IV) 1
• Primary uses:
  • Uncomplicated skin/soft tissue infections 1
  • Surgical prophylaxis for cardiac and most clean procedures 1
  • Superior cost-effectiveness and narrower spectrum reduces resistance pressure 1

Second-Generation Cephalosporins

Use second-generation agents when enhanced gram-negative or anaerobic coverage is needed, particularly for respiratory infections or surgical procedures with anaerobic contamination risk 1.

• Spectrum: Improved gram-negative activity, better β-lactamase stability, some anaerobic coverage (cefoxitin) 3, 4
• Key agents: Cefuroxime, cefoxitin 1
• Primary uses:
  • Respiratory tract infections (better activity against H. influenzae, M. catarrhalis) 1
  • Moderate-to-severe community-acquired infections 1
  • Surgical prophylaxis for procedures with anaerobic contamination risk 1

Third-Generation Cephalosporins

Reserve third-generation cephalosporins for serious gram-negative infections, necrotizing fasciitis, or complicated infections in immunocompromised hosts—NOT for routine skin infections 1.

• Spectrum: Excellent gram-negative coverage, reduced gram-positive activity compared to first-generation, NO MRSA coverage 1, 5
• Key agents: Ceftriaxone, cefotaxime (broad), ceftazidime (antipseudomonal), cefpodoxime/cefdinir (oral) 1, 3
• Primary uses:
  • Serious gram-negative infections 1
  • Necrotizing fasciitis (ceftriaxone 2g IV daily + metronidazole ± vancomycin) 1
  • Severe animal bites (with anaerobic coverage) 1
  • Respiratory infections (cefpodoxime, cefdinir) 1

Critical caveat: Meta-analyses show NO difference in treatment outcomes between cephalosporin generations for cellulitis (RR 1.00; 95% CI 0.94-1.06), making first-generation agents the rational choice 1.

Fourth-Generation Cephalosporins

• Spectrum: Excellent gram-positive and gram-negative coverage, including antibiotic-resistant Enterobacteriaceae 2, 3
• Key agent: Cefepime 2
• Use: Alternative for drug-resistant organisms 2

Fifth-Generation Cephalosporins

Fifth-generation cephalosporins are the only beta-lactams with MRSA activity and should be considered for complicated skin/soft tissue infections or MRSA bloodstream infections 1, 6.

• Spectrum: MRSA coverage plus broad gram-negative activity 1, 6
• Key agents: Ceftaroline, ceftobiprole 1, 6
• Primary uses:
  • Complicated skin/soft tissue infections including MRSA 1
  • MRSA bloodstream infections (monotherapy or combination) 6
  • Particularly useful in patients at high risk of toxicity from vancomycin or daptomycin 6

Caution: Limited data on CNS penetration; avoid as monotherapy for suspected CNS infections 6.

Dosing Principles

For serious infections with normal renal function, dose cefotaxime, ceftizoxime, and ceftazidime three times daily; ceftriaxone can be given once daily for less severe infections 5.

• Surgical prophylaxis: Single dose after anesthesia induction is sufficient; second dose only if surgery prolonged or drug has short half-life 4
• Renal adjustment: Reduce dose or frequency in elderly patients with impaired renal function 5
• Timing: Prophylaxis must begin just before operation—earlier is unnecessary and dangerous, later is less effective 4

Major Contraindications and Pitfalls

Absolute Limitations

• NO cephalosporin has activity against: Enterococci, Listeria, Corynebacterium jekeium, MRSA (except 5th generation) 5
• Third-generation agents lack: MRSA coverage (add vancomycin/linezolid if suspected) 1
• Ceftriaxone lacks: Antipseudomonal activity (use ceftazidime/cefoperazone for Pseudomonas) 1

Common Prescribing Errors

Do NOT use third-generation cephalosporins for uncomplicated skin infections—WHO and IDSA explicitly recommend against this due to reduced gram-positive activity and resistance promotion 1.

• Surgical prophylaxis misuse: Third-generation agents generally NOT recommended despite widespread use; ceftriaxone is the most commonly misused drug for prophylaxis 4
• Oral penicillin nonsusceptibility: Cannot predict cefpodoxime susceptibility in S. pneumoniae (only 78.4% categorical agreement); use caution for empiric pneumonia treatment 7

Safety Considerations

• Hypoprothrombinemia: Some agents require vitamin K supplementation (those with thiomethyl tetrazole moiety) 8
• Disulfiram-like reactions: Occur with agents containing thiomethyl tetrazole 8
• Diarrhea: Higher incidence with biliary-excreted agents, may select for resistant bacteria 8
• Superinfection risk: Reduced staphylococcal activity in some agents increases enterococcal overgrowth 8
• Allergy: Cephalosporins have fewer allergic reactions than penicillins overall 2, 4

Resistance Threats

Two major threats to third-generation cephalosporins: constitutive beta-lactamases in Enterobacter species and plasmid-mediated beta-lactamases in Klebsiella that destroy cefotaxime and ceftazidime 5.

• Resistance increasingly common due to widespread use 2
• Fourth and fifth-generation agents offer alternatives for resistant organisms 2, 6